GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CA2, CA9, CYP1A1, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MMP2, PIK3CA, PPARA, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, RORC, SRC, TRPV1 |
9.98853 |
[BP] GO:0010941 |
regulation of cell death
|
AKR1B1, APEX1, AURKB, AXL, BCL2, CYP1B1, ESR1, FLT3, GLO1, HSP90AB1, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, PRKCA, PRKCD, PRKCG, PTGS2, PTPN1, SRC, TOP2A, TRPV1, XDH |
9.55955 |
[BP] GO:0043067 |
regulation of programmed cell death
|
AKR1B1, APEX1, AURKB, AXL, BCL2, CYP1B1, ESR1, FLT3, GLO1, HSP90AB1, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARG, PRKCA, PRKCD, PRKCG, PTGS2, PTPN1, SRC, TOP2A, TRPV1, XDH |
9.50041 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CA9, CYP1A1, CYP1B1, ESR1, ESRRA, FABP3, HSP90AB1, IGF1R, MMP2, MMP9, PIK3CA, PPARA, PPARG, PRKCB, PRKCD, PRKCE, PTGS2, RORC, SRC, TRPV1 |
9.456 |
[BP] GO:0042981 |
regulation of apoptotic process
|
AKR1B1, APEX1, AURKB, AXL, BCL2, CYP1B1, ESR1, FLT3, GLO1, HSP90AB1, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PIM1, PPARG, PRKCA, PRKCD, PRKCG, PTGS2, PTPN1, SRC, TOP2A, TRPV1, XDH |
8.878 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CA2, CA9, CYP1A1, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MMP2, MMP9, PIK3CA, PPARA, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, RORC, SRC, TRPV1 |
8.64715 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CYP1A1, CYP1B1, ESR1, FABP4, FLT3, HSP90AB1, IGF1R, KDR, MMP2, PIK3CA, PPARG, PRKCB, PRKCD, PRKCE, PTGS2, RORC, SRC, TRPV1 |
8.24327 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP1, MMP2, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SLC22A2, SRC, TOP2A, XDH |
8.2432 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, AKR1B1, APEX1, AURKB, AXL, BCL2, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, ESR1, FABP3, FABP4, FLT3, HSP90AA1, HSP90AB1, KDR, MET, PIK3CA, PIK3CB, PPARA, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PTGS1, PTGS2, SLC22A1, SLC22A2, SLC22A3, SRC, TRPV1, XDH |
8.21925 |
[BP] GO:0008152 |
metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SLC22A2, SRC, TOP2A, TRPV1, XDH |
8.15464 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, AKR1B1, APEX1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TOP2A, TRPV1, XDH |
7.92391 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APEX1, BCL2, CA2, CA9, CYP1A1, CYP1B1, ESR1, ESRRA, FLT3, HSP90AB1, PPARG, PRKCE, PRKCG, PTGS2, RORC, SRC, TRPV1 |
7.71549 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CYP1A1, CYP1B1, ESR1, FABP4, FLT3, HSP90AB1, IGF1R, KDR, MMP2, MMP9, PIK3CA, PPARG, PRKCB, PRKCD, PRKCE, PTGS2, RORC, SRC, TRPV1 |
7.51772 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, APEX1, BCL2, CA2, CA9, ESR1, ESRRA, FABP3, FLT3, PPARA, PPARG, PRKCD, PRKCE, PTGS2, SRC, TRPV1 |
7.41424 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA, PPARG, SLC22A1, SLC22A2, SLC22A3, TRPV1 |
7.093 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, FABP3, FUT7, GLO1, PIK3CA, PIM1, PPARA, PPARG, PTGS1, PTGS2, XDH |
7.093 |
[BP] GO:0030168 |
platelet activation
|
AXL, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
7.01591 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.99167 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, AKR1B1, APEX1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TOP2A, TRPV1, XDH |
6.93931 |
[BP] GO:0060548 |
negative regulation of cell death
|
AKR1B1, AURKB, AXL, BCL2, GLO1, HSP90AB1, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PPARA, PRKCA, PRKCD, PRKCG, PTGS2, PTPN1, SRC |
6.86897 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, ESR1, FABP3, FABP4, FUT7, MET, PIK3CA, PIK3CB, PPARA, PPARG, PTGS1, PTGS2, TRPV1 |
6.84874 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, APEX1, AXL, BCL2, CA9, CYP1A1, CYP1B1, FABP3, HSP90AB1, KDR, PPARG, PRKCD, PRKCE, PRKCG, PTGS2, SRC, TRPV1 |
6.81988 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APEX1, AXL, CYP1B1, ESR1, IGF1R, MMP2, MMP9, PIK3CA, PPARG, PRKCB, PRKCD, PRKCE, PTGS2, RORC, SRC, TRPV1 |
6.70868 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APEX1, BCL2, CA2, CA9, ESR1, ESRRA, FABP3, FLT3, IGF1R, MMP2, PPARA, PPARG, PRKCD, PRKCE, PTGS2, SRC, TRPV1 |
6.70868 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
AKR1B1, AURKB, AXL, BCL2, GLO1, HSP90AB1, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PRKCA, PRKCD, PRKCG, PTGS2, PTPN1, SRC |
6.69208 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1B1, CYP2A13, CYP2A6 |
6.67271 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1B1, ESR1, FABP4, FLT3, HSP90AB1, IGF1R, KDR, MMP2, MMP9, PIK3CA, PPARG, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, RORC, SRC, TOP2A, TRPV1 |
6.19062 |
[BP] GO:0001775 |
cell activation
|
ALOX5, AXL, BCL2, FLT3, FUT7, HSP90AA1, HSP90AB1, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, RORC, SRC, TRPV1 |
6.06975 |
[BP] GO:0042592 |
homeostatic process
|
AKR1B1, APEX1, AXL, BCL2, CA12, CA2, CA7, ESR1, FABP3, FABP4, FLT3, HSP90AA1, HSP90AB1, MET, PIK3CA, PIK3CB, PPARG, PRKCB, PRKCE, SRC, TRPV1 |
6.05825 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APEX1, CYP1A1, CYP1B1, ESR1, FLT3, HSP90AB1, PPARG, PTGS2, RORC, SRC, TRPV1 |
6.04448 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
6.00073 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
AKR1B1, AURKB, AXL, BCL2, GLO1, HSP90AB1, IGF1R, KDR, MMP9, PIK3CA, PIM1, PRKCA, PRKCD, PRKCG, PTGS2, PTPN1, SRC |
5.99276 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CYP1B1, HSP90AB1, KDR, PRKCD, PRKCE, PTGS2, SRC, TRPV1 |
5.96253 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA, PPARG, SLC22A1, SLC22A2, SLC22A3, TRPV1 |
5.8974 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APEX1, AXL, BCL2, CA2, CYP1A1, CYP1B1, FABP4, KDR, MMP9, PRKCD, PTGS2, SRC |
5.78666 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA, PPARG, RORC, SRC |
5.53802 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
AURKB, BCL2, CDC25B, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PPARA, PPARG, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TOP2A, TRPV1, XDH |
5.50602 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, PPARG, PRKCD, PRKCE, PTGS2, SRC |
5.49201 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, APEX1, AURKB, AXL, BCL2, CDC25B, FLT3, HSP90AA1, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, XDH |
5.49201 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CYP1A1, CYP1B1, HSP90AA1, KDR, PRKCD, PRKCE, SRC |
5.49201 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, BCL2, CDC25B, FLT3, HSP90AA1, IGF1R, KDR, MET, PIK3CA, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
5.49201 |
[BP] GO:0010647 |
positive regulation of cell communication
|
AKR1B1, AXL, BCL2, CA2, CA7, CYP19A1, CYP1B1, FLT3, HSP90AB1, KDR, MET, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
5.46938 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, HSP90AA1, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PRKCA, PTPN1, SRC |
5.45894 |
[BP] GO:0023056 |
positive regulation of signaling
|
AKR1B1, AXL, BCL2, CA2, CA7, CYP19A1, CYP1B1, FLT3, HSP90AB1, KDR, MET, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
5.45039 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCL2, CA2, CA9, CYP1A1, ESR1, ESRRA, FABP3, FLT3, PPARG, PRKCE, PTGS2, RORC, SRC |
5.37504 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, PPARG, RORC, SRC |
5.37504 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CYP1A1, CYP1B1, CYP2A13, CYP2A6, FABP3, FABP4, FUT7, MET, PIK3CA, PIK3CB, PPARA, PPARG, PTGS1, PTGS2 |
5.35999 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
AURKB, BCL2, CDC25B, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PPARA, PPARG, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TOP2A, TRPV1, XDH |
5.31441 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, APEX1, AURKB, AXL, BCL2, CDC25B, FLT3, HSP90AA1, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, XDH |
5.19551 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, FABP3, FLT3, HSP90AB1, IGF1R, MMP2, PPARA, PPARG, PRKCD, PRKCE, PRKCG, PTGS2, SRC, TRPV1 |
5.11419 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2 |
5.10281 |
[BP] GO:0016310 |
phosphorylation
|
AURKB, AXL, BCL2, CDC25B, FLT3, HSP90AA1, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
5.06545 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2 |
4.98117 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
AURKB, BCL2, CDC25B, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PPARA, PPARG, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TOP2A, TRPV1, XDH |
4.86747 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1B1, CYP2A13, CYP2A6, FABP3, PPARA, PPARG, PTGS1, PTGS2 |
4.83088 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2 |
4.79359 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, AKR1B1, APEX1, AURKB, AXL, BCL2, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, HSP90AB1, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PPARA, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TOP2A, TRPV1, XDH |
4.7838 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
AKR1B1, AXL, BCL2, CYP1B1, ESRRA, FABP4, FLT3, HSP90AA1, HSP90AB1, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, XDH |
4.77205 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, FABP3, FLT3, HSP90AB1, IGF1R, MMP2, PPARA, PPARG, PRKCD, PRKCE, PRKCG, PTGS2, SRC, TRPV1 |
4.73695 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, PRKCD, SRC |
4.71223 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, PRKCD, SRC |
4.71223 |
[BP] GO:0018105 |
peptidyl-serine phosphorylation
|
AURKB, BCL2, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
4.68941 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, PPARG, RORC, SRC |
4.65401 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
BCL2, CDC25B, ESRRB, FABP3, FLT3, HSP90AB1, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
4.64595 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
BCL2, CDC25B, ESRRB, FABP3, FLT3, HSP90AB1, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
4.64595 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
BCL2, CYP1B1, HSP90AA1, HSP90AB1, PRKCD, PTGS2, TRPV1, XDH |
4.62893 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
AKR1B1, AXL, BCL2, CYP1B1, FLT3, KDR, MET, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCE, PTGS2, PTPN1, SRC, XDH |
4.59778 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1B1, CYP2A13, HSP90AB1, NQO2, PTGS1, RORC |
4.58728 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CDC25B, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SRC, TOP2A, TRPV1, XDH |
4.56507 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, MMP9, PRKCD, SRC |
4.55955 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
BCL2, CDC25B, ESRRB, FLT3, HSP90AB1, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
4.54748 |
[BP] GO:0032502 |
developmental process
|
ACHE, AKR1B1, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA9, CDC25B, CYP19A1, CYP1A1, CYP1B1, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GLO1, HSP90AB1, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, PRKCA, PRKCD, PTGS2, RORC, SRC, TOP2A |
4.49943 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.49591 |
[BP] GO:0048010 |
vascular endothelial growth factor receptor signaling pathway
|
AXL, HSP90AA1, KDR, PIK3CA, PIK3CB, SRC |
4.48425 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR, PRKCD, PRKCE |
4.4769 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, FLT3, HSP90AA1, IGF1R, KDR, MET, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP2A |
4.45919 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
AURKB, BCL2, CDC25B, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PPARA, PPARG, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TOP2A, XDH |
4.45919 |
[BP] GO:0018209 |
peptidyl-serine modification
|
AURKB, BCL2, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
4.42052 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, HSP90AA1, IGF1R, KDR, MET, PRKCD, SRC |
4.38985 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SRC |
4.38985 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, AKR1B1, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SRC, TOP2A, TRPV1 |
4.38985 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, MMP9, PRKCD, PTGS1, PTGS2, SRC |
4.38985 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, NQO2, PPARG, PTGS1, PTGS2, XDH |
4.37743 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, HSP90AA1, IGF1R, KDR, MET, PRKCD, SRC |
4.35906 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APEX1, FABP3, IGF1R, PPARA, PPARG, PRKCD, PTGS2, SRC, TRPV1 |
4.33587 |
[BP] GO:0038096 |
Fc-gamma receptor signaling pathway involved in phagocytosis
|
HSP90AA1, HSP90AB1, PIK3CA, PIK3CB, PRKCD, PRKCE, SRC |
4.30117 |
[BP] GO:0002433 |
immune response-regulating cell surface receptor signaling pathway involved in phagocytosis
|
HSP90AA1, HSP90AB1, PIK3CA, PIK3CB, PRKCD, PRKCE, SRC |
4.30117 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
AKR1B1, AURKB, AXL, BCL2, CYP1B1, ESR1, FLT3, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
4.30117 |
[BP] GO:0002431 |
Fc receptor mediated stimulatory signaling pathway
|
HSP90AA1, HSP90AB1, PIK3CA, PIK3CB, PRKCD, PRKCE, SRC |
4.26128 |
[BP] GO:0042325 |
regulation of phosphorylation
|
BCL2, CDC25B, ESRRB, FABP4, FLT3, HSP90AB1, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
4.25011 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, FLT3, HSP90AA1, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PRKCA, PTPN1, SRC |
4.23956 |
[BP] GO:0038094 |
Fc-gamma receptor signaling pathway
|
HSP90AA1, HSP90AB1, PIK3CA, PIK3CB, PRKCD, PRKCE, SRC |
4.23126 |
[BP] GO:0006950 |
response to stress
|
ACHE, AKR1B1, APEX1, AXL, BCL2, CA2, CA9, CYP1A1, CYP1B1, HSP90AA1, HSP90AB1, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PPARG, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, SRC, TOP2A, TRPV1 |
4.22972 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
AKR1B1, AXL, BCL2, CYP1B1, FLT3, HSP90AB1, KDR, MET, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
4.22362 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
CYP1A1, FABP3, FLT3, PPARA, PPARG, PRKCD, PRKCE, PTGS2, RORC, SRC |
4.21876 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, BCL2, CA12, CA2, CA7, ESR1, FABP3, FABP4, MET, PIK3CA, PIK3CB, PPARG, PRKCB, PRKCE, TRPV1 |
4.144 |
[BP] GO:0043393 |
regulation of protein binding
|
AURKB, BCL2, HSP90AB1, MET, MMP9, PPARA, PRKCD, SRC |
4.144 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
BCL2, CDC25B, FLT3, HSP90AB1, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
4.13585 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, ESR1, PPARA, PPARG, PRKCG, RORC, SRC, TOP2A |
4.13248 |
[BP] GO:0032787 |
None
|
ALOX5, CYP1A1, CYP1B1, CYP2A13, CYP2A6, FABP3, GLO1, PPARA, PPARG, PTGS1, PTGS2 |
4.06318 |
[BP] GO:0070482 |
response to oxygen levels
|
BCL2, CYP1A1, MMP2, PPARA, PPARG, PRKCB, PRKCE, PTGS2, SRC |
4.05058 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, APEX1, AXL, BCL2, CA2, CA7, CYP19A1, CYP1B1, HSP90AB1, IGF1R, KDR, MET, MMP9, PIK3CB, PPARA, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, TRPV1 |
4.04432 |
[BP] GO:2000379 |
positive regulation of reactive oxygen species metabolic process
|
HSP90AA1, HSP90AB1, PRKCD, PTGS2, TRPV1, XDH |
4.03464 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, AKR1B1, APEX1, AURKB, AXL, BCL2, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, HSP90AB1, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PPARA, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TOP2A, TRPV1, XDH |
4.02084 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
BCL2, CDC25B, ESRRB, FABP3, FABP4, FLT3, HSP90AB1, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
4.0198 |
[BP] GO:0010632 |
regulation of epithelial cell migration
|
KDR, MET, MMP9, PPARG, PRKCA, PRKCE, PTGS2, SRC |
4.0198 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CDC25B, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SRC, TOP2A, TRPV1, XDH |
4.01781 |
[BP] GO:0051972 |
regulation of telomerase activity
|
AURKB, HSP90AA1, HSP90AB1, PPARG, SRC |
4.01056 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1B1, CYP2A13, CYP2A6 |
3.98829 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
BCL2, CDC25B, ESRRB, FABP3, FABP4, FLT3, HSP90AB1, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
3.98563 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CYP1A1, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2 |
3.88413 |
[BP] GO:0009628 |
response to abiotic stimulus
|
AKR1B1, AURKB, BCL2, CA2, CYP1A1, HSP90AA1, HSP90AB1, MMP2, PPARA, PPARG, PRKCB, PRKCE, PTGS2, SRC, TRPV1 |
3.87523 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA, PPARG, PRKCB, PRKCE, SLC22A1, SLC22A2, SLC22A3, SLC47A1, TRPV1 |
3.84805 |
[BP] GO:0080134 |
regulation of response to stress
|
CYP19A1, ESR1, FABP4, HSP90AA1, HSP90AB1, IGF1R, MET, MMP2, PPARA, PPARG, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, XDH |
3.8402 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2 |
3.82113 |
[BP] GO:0042127 |
regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, CYP1B1, ESR1, ESRRA, FABP3, FLT3, IGF1R, KDR, MMP2, MMP9, PIM1, PPARG, PRKCA, PTGS1, PTGS2, SRC, XDH |
3.81725 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, PPARG, RORC |
3.81725 |
[BP] GO:0044092 |
negative regulation of molecular function
|
AURKB, CYP1B1, ESR1, FABP4, IGF1R, MET, MMP9, PIM1, PPARA, PPARG, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC |
3.79918 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.76553 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.76553 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CYP19A1, CYP1B1, ESR1, ESR2, FLT3, HSP90AB1, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
3.74425 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, BCL2, CA2, CYP19A1, CYP1A1, ESR1, ESRRA, ESRRB, FLT3, HSP90AB1, KDR, PIK3CA, PPARA, PPARG, SRC |
3.71602 |
[BP] GO:0030334 |
regulation of cell migration
|
APEX1, BCL2, CYP19A1, CYP1B1, IGF1R, KDR, MET, MMP9, PPARG, PRKCA, PRKCE, PTGS2, SRC |
3.70305 |
[BP] GO:0009894 |
regulation of catabolic process
|
APEX1, BCL2, ESRRB, HSP90AB1, KDR, MET, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTPN1 |
3.647 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CYP19A1, CYP1B1, ESR1, ESR2, FLT3, HSP90AB1, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
3.64698 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, AXL, BCL2, CA2, CA7, CYP19A1, HSP90AB1, MMP9, PIK3CB, PPARA, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, TRPV1 |
3.64613 |
[BP] GO:0031329 |
regulation of cellular catabolic process
|
APEX1, BCL2, ESRRB, HSP90AB1, KDR, MET, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCG, PTPN1 |
3.64556 |
[BP] GO:0048583 |
regulation of response to stimulus
|
AKR1B1, AURKB, AXL, BCL2, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, FABP4, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, XDH |
3.6434 |
[BP] GO:0002682 |
regulation of immune system process
|
AXL, BCL2, CA2, CYP19A1, ESR1, ESRRA, HSP90AA1, HSP90AB1, MMP2, PIK3CA, PIK3CB, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PTPN1, SRC |
3.61424 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1, PRKCD |
3.61424 |
[BP] GO:0051098 |
regulation of binding
|
AURKB, BCL2, HSP90AB1, MET, MMP9, PPARA, PPARG, PRKCD, SRC |
3.574 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
BCL2, CDC25B, FABP4, FLT3, HSP90AB1, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
3.57048 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, HSP90AA1, HSP90AB1, PTGS2, SLC22A2, SLC22A3, TRPV1 |
3.56436 |
[BP] GO:0016572 |
histone phosphorylation
|
AURKB, PRKCA, PRKCB, PRKCD |
3.55292 |
[BP] GO:0006855 |
None
|
SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2 |
3.52492 |
[BP] GO:0001666 |
response to hypoxia
|
BCL2, CYP1A1, MMP2, PPARA, PRKCB, PRKCE, PTGS2, SRC |
3.52153 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
APEX1, AURKB, BCL2, ESR1, ESR2, ESRRA, FABP4, HSP90AB1, IGF1R, MET, MMP9, PIK3CA, PPARA, PPARG, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TRPV1, XDH |
3.51418 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APEX1, ESR1, FLT3, IGF1R, MMP2, PPARG, PRKCD, PRKCE, PTGS2, SRC, TRPV1 |
3.51174 |
[BP] GO:0002521 |
leukocyte differentiation
|
AXL, BCL2, FLT3, FUT7, GLO1, MMP9, PPARG, RORC |
3.50643 |
[BP] GO:0044093 |
positive regulation of molecular function
|
AURKB, BCL2, CDC25B, ESR1, ESR2, FLT3, HSP90AA1, HSP90AB1, MET, MMP9, PIK3CA, PIK3CB, PPARG, PRKCB, PRKCD, PRKCE, PTPN1, SRC, XDH |
3.46259 |
[BP] GO:2000145 |
regulation of cell motility
|
APEX1, BCL2, CYP19A1, CYP1B1, IGF1R, KDR, MET, MMP9, PPARG, PRKCA, PRKCE, PTGS2, SRC |
3.45046 |
[BP] GO:1900076 |
regulation of cellular response to insulin stimulus
|
ESRRA, PRKCB, PRKCD, PTPN1, SRC |
3.44975 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
BCL2, CYP1A1, MMP2, PPARA, PRKCB, PRKCE, PTGS2, SRC |
3.44975 |
[BP] GO:0031399 |
regulation of protein modification process
|
BCL2, CDC25B, FABP4, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, XDH |
3.38413 |
[BP] GO:0045321 |
leukocyte activation
|
ALOX5, AXL, BCL2, FLT3, FUT7, HSP90AA1, HSP90AB1, MMP9, PRKCB, PRKCD, PRKCE, RORC, TRPV1 |
3.36323 |
[BP] GO:0032844 |
regulation of homeostatic process
|
AURKB, BCL2, CA2, CA7, KDR, PIK3CB, PRKCE, PTGS2, SRC, TRPV1 |
3.35305 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, PRKCD, SRC |
3.35305 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
APEX1, AURKB, BCL2, ESR1, ESR2, ESRRA, FABP4, HSP90AB1, IGF1R, KDR, MET, MMP9, PIK3CA, PPARA, PPARG, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TRPV1, XDH |
3.35305 |
[BP] GO:0043434 |
None
|
APEX1, FABP3, PPARA, PPARG, PRKCD, PTGS2, SRC, TRPV1 |
3.33611 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, FLT3, IGF1R, KDR, PIM1, PRKCG, SRC |
3.32985 |
[BP] GO:0065009 |
regulation of molecular function
|
AURKB, BCL2, CDC25B, CYP1B1, ESR1, ESR2, FABP4, FLT3, HSP90AA1, HSP90AB1, IGF1R, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TRPV1, XDH |
3.3294 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AXL, BCL2, CDC25B, CYP19A1, ESR1, ESRRB, HSP90AB1, PPARG, PTGS2, SRC |
3.29332 |
[BP] GO:0002429 |
immune response-activating cell surface receptor signaling pathway
|
BCL2, HSP90AA1, HSP90AB1, PIK3CA, PIK3CB, PRKCB, PRKCD, PRKCE, SRC |
3.27468 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
AURKB, ESR1, ESR2, ESRRA, ESRRB, FABP3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, PPARA, PPARG, PRKCD, PTGS2, RORC, SRC, TOP2A, TRPV1 |
3.27334 |
[BP] GO:0043065 |
positive regulation of apoptotic process
|
BCL2, CYP1B1, MMP9, PIK3CB, PPARG, PRKCD, PTGS2, SRC, TOP2A, TRPV1, XDH |
3.24941 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, PPARG, RORC |
3.22107 |
[BP] GO:0051052 |
regulation of DNA metabolic process
|
AURKB, HSP90AA1, HSP90AB1, IGF1R, PIK3CA, PPARG, PRKCD, PRKCG, SRC |
3.21738 |
[BP] GO:0043068 |
positive regulation of programmed cell death
|
BCL2, CYP1B1, MMP9, PIK3CB, PPARG, PRKCD, PTGS2, SRC, TOP2A, TRPV1, XDH |
3.21738 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
BCL2, CA2, CA7, KDR, PRKCE, SRC, TRPV1 |
3.18807 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APEX1, IGF1R, MMP2, PPARG, PRKCD, PTGS2, SRC, TRPV1 |
3.16228 |
[BP] GO:0040012 |
regulation of locomotion
|
APEX1, BCL2, CYP19A1, CYP1B1, IGF1R, KDR, MET, MMP9, PPARG, PRKCA, PRKCE, PTGS2, SRC |
3.13896 |
[BP] GO:0051054 |
positive regulation of DNA metabolic process
|
AURKB, HSP90AA1, HSP90AB1, IGF1R, PRKCD, PRKCG, SRC |
3.1311 |
[BP] GO:0070542 |
None
|
FABP3, PPARG, PRKCE, PTGS2, SRC |
3.1311 |
[BP] GO:0051270 |
regulation of cellular component movement
|
APEX1, BCL2, CYP19A1, CYP1B1, IGF1R, KDR, MET, MMP9, PPARG, PRKCA, PRKCE, PTGS2, SRC |
3.12933 |
[BP] GO:0015872 |
None
|
SLC22A1, SLC22A2, SLC22A3 |
3.11268 |
[BP] GO:0015697 |
None
|
SLC22A1, SLC22A2, SLC22A3 |
3.11268 |
[BP] GO:0015695 |
None
|
SLC22A1, SLC22A2, SLC22A3, SLC47A1 |
3.11028 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, AXL, BCL2, CDC25B, CYP19A1, CYP1A1, ESR1, ESRRB, HSP90AB1, MMP2, MMP9, PPARG, PTGS2, SRC, TOP2A |
3.10704 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, ESR1, IGF1R, MET, MMP9, PRKCD, PTGS2, PTPN1, SRC, XDH |
3.09518 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
BCL2, CDC25B, ESR1, FLT3, HSP90AB1, KDR, MMP9, PIK3CA, PIK3CB, PPARG, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
3.07516 |
[BP] GO:0038128 |
None
|
HSP90AA1, PIK3CA, PRKCA, SRC |
3.07213 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
BCL2, CDC25B, FLT3, HSP90AB1, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
3.06637 |
[BP] GO:0002768 |
immune response-regulating cell surface receptor signaling pathway
|
BCL2, HSP90AA1, HSP90AB1, PIK3CA, PIK3CB, PRKCB, PRKCD, PRKCE, SRC |
3.05107 |
[BP] GO:0032230 |
positive regulation of synaptic transmission, GABAergic
|
CA2, CA7, PRKCE |
3.01522 |
[BP] GO:0015893 |
None
|
CA2, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2 |
3.00804 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, BCL2, CYP1A1, ESR1, FLT3, MET, PIK3CB, PIM1, PRKCD, SRC |
3.00213 |
[BP] GO:1904407 |
positive regulation of nitric oxide metabolic process
|
HSP90AA1, HSP90AB1, PTGS2, TRPV1 |
2.9991 |
[BP] GO:0045429 |
positive regulation of nitric oxide biosynthetic process
|
HSP90AA1, HSP90AB1, PTGS2, TRPV1 |
2.9991 |
[BP] GO:0031347 |
regulation of defense response
|
CYP19A1, ESR1, FABP4, HSP90AB1, MMP2, PPARA, PPARG, PRKCD, PRKCE, PTGS2, PTPN1, SRC |
2.99678 |
[BP] GO:0035408 |
None
|
PRKCA, PRKCB |
2.99678 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.99678 |
[BP] GO:0010942 |
positive regulation of cell death
|
BCL2, CYP1B1, MMP9, PIK3CB, PPARG, PRKCD, PTGS2, SRC, TOP2A, TRPV1, XDH |
2.9793 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, FABP3, KDR, MMP2, PPARG, PRKCE, PTGS2, SRC |
2.96904 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APEX1, IGF1R, MMP2, PPARG, PRKCD, PTGS2, SRC, TRPV1 |
2.95201 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.9444 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, PRKCD, SRC |
2.94065 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
APEX1, AURKB, BCL2, CA9, CDC25B, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TOP2A, TRPV1, XDH |
2.9285 |
[BP] GO:0043279 |
None
|
HSP90AB1, PPARG, PRKCE, PRKCG, TRPV1 |
2.92239 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
AURKB, ESR1, ESR2, ESRRA, ESRRB, FABP3, HSP90AA1, HSP90AB1, IGF1R, MET, PPARA, PPARG, PRKCD, PTGS2, RORC, SRC, TOP2A, TRPV1 |
2.86795 |
[BP] GO:0051937 |
None
|
SLC22A1, SLC22A2, SLC22A3 |
2.86406 |
[BP] GO:0030335 |
positive regulation of cell migration
|
BCL2, IGF1R, KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SRC |
2.86004 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, MMP9, PTGS2, PTPN1, SRC |
2.84676 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
AXL, BCL2, CA1, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTPN1, SRC, TRPV1 |
2.83829 |
[BP] GO:0038093 |
Fc receptor signaling pathway
|
HSP90AA1, HSP90AB1, PIK3CA, PIK3CB, PRKCD, PRKCE, SRC |
2.83384 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
BCL2, CDC25B, ESR1, FLT3, HSP90AB1, KDR, MMP9, PIK3CA, PIK3CB, PPARG, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
2.82375 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, AURKB, AXL, BCL2, CDC25B, CYP1A1, ESR1, FLT3, FUT7, GLO1, HSP90AA1, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIK3CA, PIM1, PPARA, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, TOP2A, XDH |
2.82375 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1B1, CYP2A6, ESR1 |
2.80462 |
[BP] GO:0042752 |
None
|
PPARA, PPARG, PRKCG, RORC, TOP2A |
2.79322 |
[BP] GO:2000811 |
negative regulation of anoikis
|
BCL2, PIK3CA, SRC |
2.79322 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.79322 |
[BP] GO:2000147 |
positive regulation of cell motility
|
BCL2, IGF1R, KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SRC |
2.75792 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
APEX1, AURKB, BCL2, CA9, CDC25B, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TOP2A, TRPV1, XDH |
2.75287 |
[BP] GO:0046626 |
regulation of insulin receptor signaling pathway
|
PRKCB, PRKCD, PTPN1, SRC |
2.75102 |
[BP] GO:0009056 |
catabolic process
|
ACHE, AKR1B10, AOX1, AURKB, CYP19A1, CYP1A1, CYP1B1, CYP2A6, FABP3, FABP4, FUT7, HSP90AA1, MMP1, MMP2, MMP9, PIK3CB, SRC, XDH |
2.72252 |
[BP] GO:0008631 |
intrinsic apoptotic signaling pathway in response to oxidative stress
|
BCL2, CYP1B1, PRKCD |
2.72252 |
[BP] GO:0001525 |
angiogenesis
|
CYP1B1, KDR, MMP2, PIK3CA, PIK3CB, PRKCA, PTGS2 |
2.72252 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, APEX1, AURKB, BCL2, CA9, CDC25B, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TOP2A, TRPV1, XDH |
2.71071 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CYP1A1, CYP1B1, CYP2A13, CYP2A6, FABP3, GLO1, PIM1, PPARA, PPARG, PTGS1, PTGS2 |
2.69209 |
[BP] GO:0002684 |
positive regulation of immune system process
|
AXL, BCL2, CA2, HSP90AA1, HSP90AB1, MMP2, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, SRC |
2.68344 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
BCL2, IGF1R, KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SRC |
2.67985 |
[BP] GO:2000278 |
regulation of DNA biosynthetic process
|
AURKB, HSP90AA1, HSP90AB1, PPARG, SRC |
2.67157 |
[BP] GO:1903428 |
positive regulation of reactive oxygen species biosynthetic process
|
HSP90AA1, HSP90AB1, PTGS2, TRPV1 |
2.66667 |
[BP] GO:0010676 |
None
|
ESRRB, PPARA, PRKCE, SRC |
2.66667 |
[BP] GO:0051338 |
regulation of transferase activity
|
AURKB, CDC25B, FABP4, FLT3, HSP90AA1, HSP90AB1, IGF1R, PIK3CA, PIK3CB, PPARG, PRKCD, PTPN1, SRC |
2.66124 |
[BP] GO:0072488 |
None
|
SLC22A1, SLC22A2, SLC22A3 |
2.66124 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ALPL, AXL, BCL2, CDC25B, CYP1A1, ESR1, ESRRB, FABP4, FLT3, FUT7, GLO1, KDR, MET, MMP2, MMP9, PPARG, PRKCD, PTGS2, RORC, SRC, TOP2A |
2.66124 |
[BP] GO:0002757 |
immune response-activating signal transduction
|
BCL2, HSP90AA1, HSP90AB1, PIK3CA, PIK3CB, PRKCB, PRKCD, PRKCE, SRC |
2.64754 |
[BP] GO:0034097 |
response to cytokine
|
AXL, BCL2, FABP4, FLT3, HSP90AB1, PRKCA, PTGS2, SRC, TRPV1 |
2.64194 |
[BP] GO:0050776 |
regulation of immune response
|
BCL2, ESR1, HSP90AA1, HSP90AB1, MMP2, PIK3CA, PIK3CB, PPARG, PRKCB, PRKCD, PRKCE, PTPN1, SRC |
2.62777 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1 |
2.62777 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APEX1, AURKB, CDC25B, CYP1A1, HSP90AB1, PRKCA, PRKCE, SRC |
2.61571 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.61571 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.61571 |
[BP] GO:0048608 |
reproductive structure development
|
AXL, BCL2, CYP19A1, ESR1, HSP90AB1, PPARG, SRC |
2.61401 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.61171 |
[BP] GO:0033554 |
cellular response to stress
|
AKR1B1, APEX1, AXL, BCL2, CA2, CA9, CYP1B1, MMP9, PPARG, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TOP2A, TRPV1 |
2.60573 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, ESR1, FLT3, IGF1R, KDR, MMP2, MMP9, PIM1, PRKCA, PTGS2 |
2.60573 |
[BP] GO:0035556 |
intracellular signal transduction
|
AKR1B1, AXL, BCL2, CYP1B1, IGF1R, KDR, MET, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, SRC |
2.60507 |
[BP] GO:0007165 |
signal transduction
|
AKR1B1, AXL, BCL2, CA1, CA2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, RORC, SRC, TRPV1 |
2.60492 |
[BP] GO:0040017 |
positive regulation of locomotion
|
BCL2, IGF1R, KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SRC |
2.60094 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1 |
2.58657 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
AXL, BCL2, CA2, CYP1B1, ESRRB, KDR, MET, MMP9, PIM1, PPARG, PRKCA, PRKCB, PRKCE, PTGS2, SRC, TRPV1 |
2.58657 |
[BP] GO:1901215 |
negative regulation of neuron death
|
AXL, BCL2, HSP90AB1, PIK3CA, PPARA, PRKCG |
2.57608 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
AURKB, ESR1, ESR2, ESRRA, ESRRB, HSP90AA1, HSP90AB1, IGF1R, MET, PPARA, PPARG, PRKCD, PRKCG, PTPN1, RORC, SRC, TOP2A |
2.55851 |
[BP] GO:0045428 |
regulation of nitric oxide biosynthetic process
|
HSP90AA1, HSP90AB1, PTGS2, TRPV1 |
2.55183 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, APEX1, AURKB, BCL2, CA9, CDC25B, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TOP2A, TRPV1, XDH |
2.55088 |
[BP] GO:0051172 |
None
|
APEX1, AURKB, ESR1, ESR2, ESRRA, FABP4, HSP90AB1, IGF1R, MMP9, PPARA, PPARG, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TRPV1, XDH |
2.54482 |
[BP] GO:0050790 |
regulation of catalytic activity
|
AURKB, BCL2, CDC25B, ESR1, FABP4, FLT3, HSP90AA1, HSP90AB1, IGF1R, MMP9, PIK3CA, PIK3CB, PPARG, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
2.53668 |
[BP] GO:0009966 |
regulation of signal transduction
|
AKR1B1, AURKB, AXL, BCL2, CYP1B1, ESR1, ESR2, FLT3, HSP90AB1, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
2.50018 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.50006 |
[BP] GO:0015844 |
None
|
SLC22A1, SLC22A2, SLC22A3 |
2.50006 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, APEX1, AURKB, BCL2, CA9, CDC25B, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP4, FLT3, GLO1, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TOP2A, TRPV1, XDH |
2.48557 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, PRKCA, PRKCE, SLC22A1 |
2.47691 |
[BP] GO:0002764 |
immune response-regulating signaling pathway
|
BCL2, HSP90AA1, HSP90AB1, PIK3CA, PIK3CB, PRKCB, PRKCD, PRKCE, SRC |
2.47167 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.44419 |
[BP] GO:0050996 |
None
|
PPARA, PRKCD, PRKCE |
2.44419 |
[BP] GO:0010675 |
None
|
ESRRB, PPARA, PRKCE, RORC, SRC |
2.4391 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
CYP19A1, ESR1, FABP4, KDR, MET, PPARA, PPARG, PRKCA, PRKCD, PRKCG, PTGS2 |
2.42659 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
AURKB, BCL2, CDC25B, ESR1, FLT3, HSP90AA1, HSP90AB1, PIK3CA, PIK3CB, PPARG, PRKCD, PRKCE, PTPN1, SRC, XDH |
2.40203 |
[BP] GO:2000209 |
regulation of anoikis
|
BCL2, PIK3CA, SRC |
2.3925 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, HSP90AA1, HSP90AB1, SRC |
2.38127 |
[BP] GO:0015874 |
None
|
SLC22A1, SLC22A2 |
2.36998 |
[BP] GO:1901374 |
None
|
SLC22A1, SLC22A2 |
2.36998 |
[BP] GO:1905323 |
None
|
HSP90AA1, HSP90AB1 |
2.36998 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.36998 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX5, CYP1A1, CYP1B1, CYP2A13, CYP2A6, FABP3, GLO1, PIM1, PPARA, PPARG, PTGS1, PTGS2 |
2.36138 |
[BP] GO:0071453 |
cellular response to oxygen levels
|
BCL2, PPARG, PRKCE, PTGS2, SRC |
2.36114 |
[BP] GO:1901653 |
cellular response to peptide
|
AKR1B1, APEX1, IGF1R, PPARG, PRKCD, SRC |
2.34979 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, MMP2, MMP9, PPARG, PTGS2 |
2.34875 |
[BP] GO:0002253 |
activation of immune response
|
BCL2, HSP90AA1, HSP90AB1, PIK3CA, PIK3CB, PRKCB, PRKCD, PRKCE, SRC |
2.32654 |
[BP] GO:0050801 |
ion homeostasis
|
BCL2, CA12, CA2, CA7, ESR1, FABP3, PIK3CB, PRKCB, PRKCE, TRPV1 |
2.32654 |
[BP] GO:0030155 |
regulation of cell adhesion
|
BCL2, CYP1B1, KDR, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, SRC |
2.32654 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, MET, PIK3CA, PIK3CB, SRC, XDH |
2.3217 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, BCL2, ESR1, ESR2, IGF1R, MET, MMP9, PPARG, PRKCB, PRKCD, PTGS2, PTPN1, SRC, XDH |
2.31517 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, AXL, BCL2, CA2, CYP19A1, HSP90AB1, PPARG, PRKCD, PRKCE, PTGS2, SRC, TRPV1 |
2.3089 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, BCL2, ESR1, ESR2, IGF1R, MET, MMP9, PPARG, PRKCB, PRKCD, PTGS2, PTPN1, SRC, XDH |
2.30317 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX5, CYP1A1, CYP1B1, CYP2A13, CYP2A6, FABP3, GLO1, PIM1, PPARA, PPARG, PTGS1, PTGS2 |
2.30311 |
[BP] GO:0045913 |
None
|
ESRRB, PPARA, PRKCE, SRC |
2.30311 |
[BP] GO:0002376 |
immune system process
|
ALOX5, AXL, BCL2, FLT3, FUT7, HSP90AA1, HSP90AB1, IGF1R, MMP1, MMP9, PIK3CA, PIK3CB, PPARG, PRKCB, PRKCD, PRKCE, RORC, SRC, TRPV1 |
2.29314 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, GLO1 |
2.28071 |
[BP] GO:0045088 |
regulation of innate immune response
|
ESR1, HSP90AB1, MMP2, PPARG, PRKCD, PRKCE, PTPN1, SRC |
2.27697 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
AURKB, CDC25B, FLT3, HSP90AA1, HSP90AB1, PIK3CA, PIK3CB, PRKCD, PTPN1, SRC |
2.25516 |
[BP] GO:0030100 |
regulation of endocytosis
|
AXL, PIK3CB, PPARG, PRKCG, PTPN1, SRC |
2.24735 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, BCL2, CA2, FLT3, PTGS2, SRC |
2.24735 |
[BP] GO:0009991 |
response to extracellular stimulus
|
ALPL, AXL, BCL2, CYP1A1, PPARG, PTGS2, SRC, TRPV1 |
2.23381 |
[BP] GO:0046649 |
lymphocyte activation
|
AXL, BCL2, FLT3, FUT7, PRKCB, PRKCD, RORC |
2.23064 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
BCL2, CYP19A1, ESR1, ESR2, IGF1R, MET, MMP9, PPARA, PPARG, PRKCB, PRKCD, PTGS2, PTPN1, SRC, XDH |
2.22769 |
[BP] GO:0050793 |
regulation of developmental process
|
AXL, BCL2, CA2, CYP1B1, ESR1, ESRRA, ESRRB, HSP90AB1, KDR, PIK3CA, PIM1, PPARA, PPARG, PRKCA, PRKCB, PTGS2, RORC, SRC, TRPV1, XDH |
2.22213 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, PRKCD, SRC |
2.22213 |
[BP] GO:0043524 |
negative regulation of neuron apoptotic process
|
AXL, BCL2, HSP90AB1, PIK3CA, PRKCG |
2.22213 |
[BP] GO:0002252 |
None
|
ALOX5, BCL2, FUT7, HSP90AA1, HSP90AB1, MMP9, PIK3CA, PIK3CB, PRKCD, PRKCE, RORC, SRC |
2.21677 |
[BP] GO:0046618 |
None
|
SLC47A1, SLC47A2 |
2.1893 |
[BP] GO:0032800 |
receptor biosynthetic process
|
ACHE, PPARG |
2.1893 |
[BP] GO:0010891 |
None
|
PPARA, PPARG |
2.1893 |
[BP] GO:0046320 |
None
|
FABP3, PPARA, PPARG |
2.18495 |
[BP] GO:0032501 |
multicellular organismal process
|
AKR1B1, AKR1B10, ALOX5, ALPL, AXL, BCL2, CYP19A1, CYP1B1, ESR1, ESRRB, FABP4, IGF1R, MET, MMP1, MMP2, MMP9, PIK3CA, PIM1, PPARA, PRKCD, PRKCG, PTGS2, RORC, SRC, TRPV1 |
2.17676 |
[BP] GO:0019538 |
protein metabolic process
|
ACHE, ALPL, AURKB, AXL, BCL2, CDC25B, ESR1, FLT3, FUT7, HSP90AA1, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIK3CA, PIM1, PPARA, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, SRC, TOP2A |
2.17147 |
[BP] GO:0051726 |
regulation of cell cycle
|
APEX1, AURKB, BCL2, CDC25B, CYP1A1, HSP90AA1, HSP90AB1, PIM1, PRKCA, PRKCE, PTGS2, SRC, TOP2A |
2.16409 |
[BP] GO:1901342 |
regulation of vasculature development
|
CYP1B1, KDR, PPARG, PRKCA, PRKCB, PTGS2, XDH |
2.15709 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
AURKB, AXL, BCL2, ESR1, IGF1R, KDR, MET, MMP1, MMP9, PPARG, PRKCD, PRKCE, SRC |
2.14784 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, MMP2, MMP9, PTGS2 |
2.14525 |
[BP] GO:0007568 |
aging
|
APEX1, AURKB, BCL2, CYP1A1, PRKCD, PTGS2 |
2.14381 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
AXL, BCL2, CA2, CYP1B1, ESR1, ESRRA, ESRRB, HSP90AB1, KDR, MET, MMP9, PIK3CA, PIM1, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, SRC, TRPV1, XDH |
2.13 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
FLT3, IGF1R, KDR, PIK3CB, PRKCA, PRKCD, PRKCE, PTPN1, SRC, XDH |
2.11789 |
[BP] GO:0018107 |
peptidyl-threonine phosphorylation
|
BCL2, PRKCA, PRKCB, PRKCD |
2.11205 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
BCL2, ESR1, ESR2, IGF1R, MET, MMP9, PPARG, PRKCB, PRKCD, PTGS2, PTPN1, SRC, XDH |
2.11205 |
[BP] GO:0035265 |
organ growth
|
BCL2, CYP19A1, ESR1 |
2.11205 |
[BP] GO:0046627 |
None
|
PRKCB, PRKCD, PTPN1 |
2.11205 |
[BP] GO:0050778 |
positive regulation of immune response
|
BCL2, HSP90AA1, HSP90AB1, MMP2, PIK3CA, PIK3CB, PRKCB, PRKCD, PRKCE, SRC |
2.10605 |
[BP] GO:0032870 |
cellular response to hormone stimulus
|
APEX1, ESR1, FLT3, PPARG, PRKCD, PRKCE, SRC |
2.07847 |
[BP] GO:0045923 |
None
|
PPARA, PPARG, PTGS2 |
2.07608 |
[BP] GO:0014065 |
phosphatidylinositol 3-kinase signaling
|
IGF1R, PIK3CA, PIK3CB |
2.07608 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, MET, PIK3CA, PIK3CB, SRC |
2.05907 |
[BP] GO:1901655 |
None
|
AKR1B1, PPARG, PRKCE, SRC |
2.05904 |
[BP] GO:0051128 |
regulation of cellular component organization
|
AURKB, AXL, BCL2, ESR1, ESR2, HSP90AA1, IGF1R, KDR, MET, MMP1, MMP9, PIK3CB, PPARG, PRKCD, PRKCE, PRKCG, PTPN1, SRC, TOP2A |
2.05311 |
[BP] GO:0010887 |
None
|
PPARA, PPARG |
2.05311 |
[BP] GO:0010871 |
None
|
PPARA, PPARG |
2.05311 |
[BP] GO:0051902 |
negative regulation of mitochondrial depolarization
|
BCL2, SRC |
2.05311 |
[BP] GO:0046113 |
None
|
AOX1, XDH |
2.05311 |
[BP] GO:0033273 |
response to vitamin
|
ALPL, CYP1A1, PPARG, PTGS2 |
2.05022 |
[BP] GO:1903426 |
None
|
HSP90AA1, HSP90AB1, PTGS2, TRPV1 |
2.05022 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
CA2, CA7, PRKCE |
2.04996 |
[BP] GO:0045766 |
positive regulation of angiogenesis
|
CYP1B1, KDR, PRKCA, PRKCB, PTGS2 |
2.04756 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, FLT3, PTGS2, SRC |
2.0355 |
[BP] GO:0038127 |
None
|
HSP90AA1, PIK3CA, PRKCA, SRC |
2.03408 |
[BP] GO:0010605 |
negative regulation of macromolecule metabolic process
|
APEX1, AURKB, ESR1, ESR2, ESRRA, FABP4, HSP90AB1, IGF1R, KDR, MMP9, PPARA, PPARG, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TRPV1, XDH |
2.02631 |
[BP] GO:0010594 |
regulation of endothelial cell migration
|
KDR, MET, PPARG, PRKCA, PTGS2 |
2.02561 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
BCL2, CDC25B, ESR1, FABP4, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PPARG, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, XDH |
2.02313 |
[BP] GO:0019217 |
None
|
FABP3, PPARA, PPARG, PTGS2 |
2.01902 |
[BP] GO:1900077 |
None
|
PRKCB, PRKCD, PTPN1 |
2.01902 |
[BP] GO:0010907 |
None
|
ESRRB, PPARA, SRC |
2.01902 |
[BP] GO:0006810 |
None
|
ACHE, ALOX5, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, HSP90AA1, HSP90AB1, MMP9, PPARA, PPARG, PRKCB, PRKCD, PRKCE, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2, SRC, TRPV1, XDH |
2.01257 |
[BP] GO:0071396 |
cellular response to lipid
|
AXL, ESR1, FLT3, PPARG, PRKCE, RORC, SRC |
2.01017 |
[BP] GO:2001242 |
regulation of intrinsic apoptotic signaling pathway
|
BCL2, MMP9, PTGS2, PTPN1, SRC |
2.00708 |
[BP] GO:0018210 |
peptidyl-threonine modification
|
BCL2, PRKCA, PRKCB, PRKCD |
2.00553 |
[BP] GO:0010595 |
positive regulation of endothelial cell migration
|
KDR, MET, PRKCA, PTGS2 |
2.00553 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ALPL, AXL, CA12, CA14, CA2, CA4, CA9, ESR1, FLT3, GLO1, HSP90AA1, IGF1R, KDR, MET, MMP2, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2, SRC, TRPV1 |
3.37754 |
[CC] GO:0016020 |
membrane
|
ACHE, ALOX5, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, ESR1, FLT3, FUT7, GLO1, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP2, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2, SRC, TRPV1 |
2.60795 |
[CC] GO:0048471 |
perinuclear region of cytoplasm
|
ACHE, AKR1B1, APEX1, CA4, PPARG, PRKCA, PRKCD, PRKCE, PRKCG, SRC |
2.42598 |
[CC] GO:0005783 |
None
|
APEX1, BCL2, CA4, CYP19A1, FLT3, KDR, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, XDH |
2.38186 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ACHE, AKR1B1, AKR1B10, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA2, CA4, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, HSP90AA1, HSP90AB1, IGF1R, KDR, MMP2, MMP9, NQO2, PIK3CB, PIM1, PPARA, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SLC22A2, SLC47A1, SRC, TOP2A, XDH |
2.2709 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, AURKB, BCL2, CA1, CA2, CA4, CA7, CDC25B, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, FABP3, FABP4, FLT3, FUT7, GLO1, HSP90AA1, HSP90AB1, KDR, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, SRC, TOP2A, TRPV1, XDH |
2.07608 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
2.05311 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP2, MMP9, NQO2, PIM1, PPARA, PPARG, PRKCA, PRKCB, PRKCG, PTPN1, RORC, XDH |
17.043 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SRC, TOP2A, TRPV1, XDH |
12.732 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP2, MMP9, NQO2, PPARA, PPARG, PRKCA, PRKCB, PRKCG, PTPN1, RORC |
10.1888 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
9.98853 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, AOX1, APEX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP2, MMP9, NQO2, PIM1, PPARA, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, TOP2A, TRPV1, XDH |
9.456 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, AOX1, APEX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP2, MMP9, NQO2, PIM1, PPARA, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, TOP2A, TRPV1, XDH |
9.04774 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CYP19A1, CYP1A1, CYP1B1, CYP2A13, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP2A, TRPV1 |
8.46049 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, FLT3, FUT7, GLO1, HSP90AA1, IGF1R, KDR, MET, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, SRC, TOP2A, XDH |
8.15464 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.93667 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, PPARG, RORC |
6.75036 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, PPARG, RORC |
6.75036 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.44514 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, PPARG, RORC |
6.23539 |
[MF] GO:0004697 |
None
|
PRKCA, PRKCB, PRKCD, PRKCE, PRKCG |
6.08013 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, FLT3, HSP90AA1, IGF1R, KDR, MET, PIK3CA, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
5.84168 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, FLT3, HSP90AA1, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
5.68252 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, GLO1 |
5.41707 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2, SRC |
5.41435 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, FLT3, HSP90AA1, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
5.25652 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2, SRC |
5.19739 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6 |
5.14589 |
[MF] GO:0043560 |
insulin receptor substrate binding
|
IGF1R, PIK3CA, PIK3CB, PRKCD |
4.95899 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, XDH |
4.77205 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, NQO2, PTGS1, PTGS2, XDH |
4.58728 |
[MF] GO:0036094 |
small molecule binding
|
AOX1, AURKB, AXL, FABP3, FABP4, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, NQO2, PIK3CA, PIK3CB, PIM1, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP2A, TRPV1, XDH |
4.56481 |
[MF] GO:0004698 |
None
|
PRKCA, PRKCB, PRKCG |
4.49591 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, HSP90AA1, IGF1R, KDR, MET, PRKCD, SRC |
4.45919 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, FLT3, HSP90AA1, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
4.4566 |
[MF] GO:0005524 |
ATP binding
|
AURKB, AXL, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP2A, TRPV1 |
4.36367 |
[MF] GO:0032559 |
adenyl ribonucleotide binding
|
AURKB, AXL, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP2A, TRPV1 |
4.23956 |
[MF] GO:0030554 |
adenyl nucleotide binding
|
AURKB, AXL, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP2A, TRPV1 |
4.21293 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, NQO2, PTGS1, PTGS2, SRC, XDH |
4.03739 |
[MF] GO:0000166 |
nucleotide binding
|
AOX1, AURKB, AXL, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, NQO2, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP2A, TRPV1, XDH |
3.98829 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
AOX1, AURKB, AXL, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, NQO2, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP2A, TRPV1, XDH |
3.9878 |
[MF] GO:0005329 |
None
|
SLC22A1, SLC22A2, SLC22A3 |
3.96477 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2 |
3.88413 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1B1, CYP2A13 |
3.84452 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, AOX1, BCL2, ESR1, ESR2, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP9, NQO2, PPARG, PTGS2, SLC22A1, TOP2A, TRPV1, XDH |
3.83925 |
[MF] GO:0043168 |
anion binding
|
AOX1, AURKB, AXL, FABP3, FABP4, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, NQO2, PIK3CA, PIK3CB, PIM1, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP2A, TRPV1, XDH |
3.83109 |
[MF] GO:0030235 |
nitric-oxide synthase regulator activity
|
ESR1, HSP90AA1, HSP90AB1 |
3.76553 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.58139 |
[MF] GO:1901363 |
heterocyclic compound binding
|
AOX1, APEX1, AURKB, AXL, BCL2, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SRC, TOP2A, TRPV1, XDH |
3.51259 |
[MF] GO:0008504 |
None
|
SLC22A1, SLC22A2, SLC22A3 |
3.45046 |
[MF] GO:0015651 |
None
|
SLC22A1, SLC22A2, SLC22A3 |
3.45046 |
[MF] GO:0097159 |
organic cyclic compound binding
|
AOX1, APEX1, AURKB, AXL, BCL2, CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SRC, TOP2A, TRPV1, XDH |
3.44975 |
[MF] GO:0035639 |
purine ribonucleoside triphosphate binding
|
AURKB, AXL, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP2A, TRPV1 |
3.27199 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6 |
3.26674 |
[MF] GO:0019899 |
enzyme binding
|
AURKB, BCL2, CDC25B, CYP1A1, CYP2A6, ESR1, ESR2, ESRRB, HSP90AA1, HSP90AB1, MET, PPARA, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TOP2A |
3.24693 |
[MF] GO:0009931 |
None
|
PRKCA, PRKCB, PRKCG |
3.21024 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.14985 |
[MF] GO:0032555 |
purine ribonucleotide binding
|
AURKB, AXL, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP2A, TRPV1 |
3.14656 |
[MF] GO:0017076 |
purine nucleotide binding
|
AURKB, AXL, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP2A, TRPV1 |
3.11604 |
[MF] GO:0032553 |
ribonucleotide binding
|
AURKB, AXL, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP2A, TRPV1 |
3.11268 |
[MF] GO:0010857 |
None
|
PRKCA, PRKCB, PRKCG |
3.11268 |
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, ESRRA, ESRRB, RORC |
3.00804 |
[MF] GO:0004666 |
prostaglandin-endoperoxide synthase activity
|
PTGS1, PTGS2 |
2.99678 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.99678 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.99678 |
[MF] GO:0035403 |
None
|
PRKCA, PRKCB |
2.99678 |
[MF] GO:0035258 |
None
|
ESR1, FLT3, PPARG, PRKCB, SRC |
2.97938 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, APEX1, ESRRB, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC |
2.9793 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.90558 |
[MF] GO:0008289 |
lipid binding
|
AXL, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, PPARA, PPARG, RORC, TRPV1 |
2.904 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1B1, CYP2A13 |
2.86969 |
[MF] GO:0015238 |
None
|
SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2 |
2.86406 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1B1, CYP2A13, CYP2A6 |
2.84676 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, APEX1, ESRRB, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MMP9, PIM1, PPARA, PTPN1, SRC |
2.76159 |
[MF] GO:0035173 |
histone kinase activity
|
AURKB, PRKCA, PRKCB |
2.72252 |
[MF] GO:0008134 |
transcription factor binding
|
APEX1, BCL2, ESR1, ESRRB, FLT3, PIM1, PPARA, PPARG, PRKCB, SRC |
2.69231 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, NQO2, XDH |
2.62777 |
[MF] GO:0015307 |
None
|
SLC47A1, SLC47A2 |
2.61571 |
[MF] GO:1901375 |
None
|
SLC22A1, SLC22A2 |
2.61571 |
[MF] GO:0005333 |
None
|
SLC22A1, SLC22A2 |
2.61571 |
[MF] GO:0005277 |
None
|
SLC22A1, SLC22A2 |
2.61571 |
[MF] GO:0008513 |
None
|
SLC22A1, SLC22A2 |
2.61571 |
[MF] GO:0004699 |
None
|
PRKCD, PRKCE |
2.61571 |
[MF] GO:0140096 |
catalytic activity, acting on a protein
|
AURKB, AXL, CDC25B, FLT3, HSP90AA1, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIK3CA, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, SRC |
2.3925 |
[MF] GO:0042803 |
protein homodimerization activity
|
ACHE, AOX1, BCL2, FLT3, HSP90AA1, HSP90AB1, NQO2, PTGS2, SLC22A1, TOP2A, XDH |
2.38372 |
[MF] GO:0097367 |
carbohydrate derivative binding
|
AURKB, AXL, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP2A, TRPV1 |
2.3828 |
[MF] GO:0019900 |
None
|
AURKB, CDC25B, ESR1, HSP90AA1, HSP90AB1, PRKCB, PRKCD, PTPN1, SRC, TOP2A |
2.36998 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.36998 |
[MF] GO:0015101 |
None
|
SLC22A1, SLC22A2, SLC22A3 |
2.35233 |
[MF] GO:0005504 |
None
|
FABP3, FABP4, PPARG |
2.22255 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.1893 |
[MF] GO:0019901 |
None
|
CDC25B, ESR1, HSP90AA1, HSP90AB1, PRKCB, PRKCD, PTPN1, SRC, TOP2A |
2.1309 |
[MF] GO:0004674 |
protein serine/threonine kinase activity
|
AURKB, PIK3CA, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG |
2.11789 |
[MF] GO:0008519 |
None
|
SLC22A1, SLC22A2, SLC22A3 |
2.11205 |
[MF] GO:0035257 |
None
|
ESR1, FLT3, PPARG, PRKCB, SRC |
2.10605 |
[MF] GO:0005158 |
None
|
IGF1R, PTPN1, SRC |
2.07608 |
[MF] GO:0050543 |
None
|
FABP3, PPARG |
2.05311 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.05311 |
[MF] GO:0043546 |
None
|
AOX1, XDH |
2.05311 |